Description

The Tumor Test Marker YRA385 // YRA391 is a cutting-edge diagnostic tool designed for use with chemiluminescence immunoassay analyzers, capable of detecting 18 different tumor markers. Its primary function is to play a crucial role in early cancer detection by identifying elevated tumor marker levels in the blood, which aids in diagnosing and recognizing various malignant tumors. With models such as YRA385 and YRA391, this test kit offers a comprehensive range of tumor marker detection, making it an invaluable resource in the medical field.

Market Price

The market price for the Tumor Test Marker YRA385 // YRA391 kits generally ranges between $300 and $600, depending on the model and the test capacity of each kit. While prices may vary based on distributor and bulk purchase agreements, customers can request specific quotations or utilize the Kalstein Plus platform for automated quote generation, offering the most competitive pricing options available.

Frequently Asked Questions

What is the main use of the Tumor Test Marker YRA385 // YRA391? The main use is for the early detection of cancer through the identification of elevated tumor marker levels in the blood.

How many tests are included in each package? The kits are available with 50, 100, or 24 tests per box.

What certifications does this product have? The product is certified with CE, ISO13485, and FSC.

Advantages and Disadvantages

The primary advantage of the Tumor Test Marker YRA385 // YRA391 lies in its ability to detect a wide range of tumor markers accurately, which is vital for early cancer diagnosis. It is compatible with standard CLIA analysis modes and operates at a storage temperature of 2-8°C, ensuring reliability. However, a potential disadvantage is the cost, which might be higher compared to simpler diagnostic tests. Additionally, specialized equipment is needed to perform the analysis, which might not be available in all healthcare settings.

Usage in the Field

In practical scenarios, the Tumor Test Marker YRA385 // YRA391 is used extensively in laboratories and hospitals equipped with chemiluminescence immunoassay analyzers. It facilitates the screening process for various cancers by providing early warnings through elevated marker levels, thereby enabling timely medical intervention. This is crucial in personalized treatment plans and improving patient outcomes.

Recommendations

To maximize the accuracy and efficiency of the Tumor Test Marker YRA385 // YRA391, it is recommended to adhere to the specified storage conditions and ensure that calibration is performed correctly with 2/6 points as outlined in the guidelines. Regular maintenance of the immunoassay analyzers and proper training of the laboratory personnel are also advised for optimal performance of the test kits. For more details or to obtain a competitive quote, visit the Kalstein Plus platform today.

Features

• Chemiluminescence immunoassay analyzer compatible
• Detects 18 different tumor markers
• Models include YRA385, YRA391
• Available in packages of 50T/BOX, 100T/BOX, 24T/BOX
• Certified CE, ISO13485, FSC

Technical Specifications